According to a study, vaccines for MMR and Tdap -- Measles-Mumps-Rubella and Tetanus-Diphtheria-Pertussis -- have…
PRIOR MMR OR Tdap VACCINATION MAY REDUCE RISK OF SEVERE COVID-19
Researchers in the United States have shown that prior Measles-Mumps-Rubella (MMR) or Tetanus-Diphtheria-pertussis (Tdap) vaccination may reduce the risk of severe outcomes in patients with coronavirus disease 2019 (COVID-19).
The team provided evidence that infection with the COVID-19 causative agent – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – reactivates memory T cells previously generated by MMR and Tdap vaccination and that this may reduce the severity of COVID-19.
Source: NEWS Medical Life Sciences